Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

418 projects found matching your search criteria :

  1. Synthesis and study of anticancer activities and affinities to kinesin of selected sandwich and half-sandwich organometa...

    Call: OPUS 9 , Panel: ST5

    Principal investigator: dr hab. Damian Plażuk

    Uniwersytet Łódzki, Wydział Chemii

  2. New MOF compounds as degradable nanocontainers of tyrosine kinases inhibitors in novel anti-cancer therapy

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Artur Terzyk

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  3. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese...

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Maria Bretner

    Politechnika Warszawska, Wydział Chemiczny

  4. Modification of cellular aging in vitro by inhibitors of non-enzymatic protein modifications

    Call: OPUS 9 , Panel: NZ3

    Principal investigator: prof. Grzegorz Bartosz

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

  5. In vivo and in vitro structure of influenza virus RNA. The structural determinants behind the inhibition of influenza vi...

    Call: OPUS 10 , Panel: NZ1

    Principal investigator: prof. Elżbieta Kierzek

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  6. Tick-borne encephalitis virus - search for mechanisms useful in treatment and prophylaxis.

    Call: SONATA 10 , Panel: NZ6

    Principal investigator: dr hab. Ewelina Król

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  7. Dynamic Relation between Repetitive Negative Thinking and Inhibition in Depression - Daily Process Approach

    Call: POLONEZ 2 , Panel: HS6

    Principal investigator: dr Monika Kornacka

    SWPS Uniwersytet Humanistycznospołeczny w Warszawie, Wydział Psychologii

  8. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the primary open-angle glaucoma treatmen...

    Call: OPUS 11 , Panel: NZ5

    Principal investigator: prof. Ireneusz Majsterek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  9. Molecular aspects of interference with the thymidylate synthase-catalyzed reaction mechanism by the slow-binding inhibit...

    Call: OPUS 11 , Panel: NZ1

    Principal investigator: prof. Wojciech Rode

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

  10. Structure and function characterization of newly discovered unique inhibitors of proteases

    Call: OPUS 11 , Panel: NZ1

    Principal investigator: prof. Jan Potempa

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  11. Synthesis and biological evaluation of novel, drug-like multifunctional ligands, as potential anti-Alzheimer's agents ta...

    Call: PRELUDIUM 11 , Panel: NZ7

    Principal investigator: Dawid Panek

    Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  12. Biased inverse agonists of 5-HT6 receptor and dual 5-HT6/MAO-B inhibitors - in search for new therapeutic approaches for...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Paweł Zajdel

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  13. Spectroscopic studies in micro- and nanoscale of the corrosion process and its inhibition of the modified metallic surfa...

    Call: SONATA 15 , Panel: ST4

    Principal investigator: dr Dominika Maria Święch

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Akademickie Centrum Materiałów i Nanotechnologii AGH

  14. SufA bacterial protease inhibitors as potential diagnostic tools and antibacterial agents.

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Ewa Magdalena Burchacka

    Politechnika Wrocławska

  15. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  16. Structure optimization of the PD-1/PD-L1 inhibitors based on the terphenyl scaffold

    Call: PRELUDIUM 19 , Panel: ST4

    Principal investigator: dr Damian Muszak

    Uniwersytet Jagielloński, Wydział Chemii

  17. Role of cereal leaf beetle – associated bacteria in the adaptation of their insect host to the insecticides and protease...

    Call: PRELUDIUM 19 , Panel: NZ9

    Principal investigator: Beata Wielkopolan

    Instytut Ochrony Roślin - Państwowy Instytut Badawczy

  18. The influence of natural plant extracts obtained by supercritical extraction on the replication inhibition of the most i...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Grzegorz Jan Woźniakowski

    Uniwersytet Mikołaja Kopernika w Toruniu

  19. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  20. Iron chelators as tyrosine kinase inhibitors - a new strategy for the treatment of glioblastoma multiforme

    Call: PRELUDIUM BIS 2 , Panel: NZ5

    Principal investigator: dr hab. Anna Dominika Mrozek-Wilczkiewicz

    Uniwersytet Śląski w Katowicach, Wydział Nauk Ścisłych i Technicznych

  21. Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental thera...

    Call: WEAVE-UNISONO , Panel: NZ7

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński

  22. The SAR analysis and synthesis of complex, small molecule PD-1/PD-L1 interaction antagonists

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Magdalena Maria Żarnik

    Uniwersytet Jagielloński, Wydział Chemii

  23. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  24. An influence of lipoproteins on fibrinolysis and pleiotropic effect of proprotein convertase subtilisin/kexin type 9 (PC...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Magdalena Teresa Kopytek

    Krakowski Szpital Specjalistyczny im. Jana Pawła II

  25. The role of glycosylation of structural proteins in the life cycle of SARS-CoV-2 coronavirus.

    Call: OPUS 21 , Panel: NZ6

    Principal investigator: dr hab. Ewelina Król

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  26. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

  27. Lipidic liquid-crystalline nanomaterials for reconstitution and physico-chemical studies of membrane proteins

    Call: OPUS 22 , Panel: ST4

    Principal investigator: prof. Renata Bilewicz

    Uniwersytet Warszawski, Wydział Chemii

  28. Combinatorial targeting of non-genetic sources of cell-to-cell heterogeneity to overcome fractional killing of cancer ce...

    Call: SONATA 17 , Panel: NZ3

    Principal investigator: dr Jarosław Walczak

    Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk

  29. SELECTIVE REGULATION OF RAB GTPASES BY TARGETING PROTEIN-PROTEIN INTERACTIONS BETWEEN RABS AND REGULATORY PROTEINS

    Call: PRELUDIUM BIS 3 , Panel: ST4

    Principal investigator: dr hab. Katarzyna Magdalena Błażewska

    Politechnika Łódzka, Wydział Chemiczny

  30. The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on changes in selected epigenetic mechan...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Agnieszka Magdalena Woźniak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  31. Mechanisms and therapeutic potential of SGLT2/SGLT1 and NHE-1 inhibition in a rat model of heart failure with preserved ...

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Urszula Mackiewicz

    Centrum Medyczne Kształcenia Podyplomowego

  32. The role of diet in the development of autoimmune diseases - new interleukin 15 inhibitors among dietary polyphenols and...

    Call: SONATA 18 , Panel: NZ9

    Principal investigator: dr Barbara Joanna Żyżyńska-Granica

    Warszawski Uniwersytet Medyczny

  33. Feel the chemistry if you're close enough - proximity-induced SuFEx ligation for mRNA biology and medicine

    Call: OPUS 25 , Panel: ST5

    Principal investigator: prof. Jacek Jemielity

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  34. Multiparameter analysis of co-inhibitory and co-stimulatory immune checkpoints and their role in the induction of immuno...

    Call: PRELUDIUM 22 , Panel: NZ6

    Principal investigator: Dorota Suszczyk

    Uniwersytet Medyczny w Lublinie

  35. The effect of Tcf7l2 knockout on excitation/inhibition balance in neuronal circuits of the thalamus

    Call: PRELUDIUM 22 , Panel: NZ3

    Principal investigator: Katarzyna Hryniewiecka

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  36. The design and development of the peptide inhibitors library targeting Zn(II)-binding site of matrix metalloproteinases ...

    Call: PRELUDIUM 22 , Panel: ST5

    Principal investigator: Paulina Alicja Potok

    Uniwersytet Wrocławski, Wydział Chemii

  37. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve...

    Call: OPUS 25 , Panel: ST4

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

  38. Molecular mechanisms of DNA damage triggered by PIM kinases inhibition and its consequences for activation of innate imm...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

  39. The inhibition of NMDAR and TRPM4 coupling - a hope for novel therapeutic target for the treatment of the ischemic brain...

    Call: SONATA BIS 13 , Panel: NZ7

    Principal investigator: dr Bartosz Pomierny

    Uniwersytet Jagielloński, Collegium Medicum

  40. Early Intervention with mTOR Inhibitors for Neuropsychiatric Symptoms in Tuberous Sclerosis Complex: Unveiling Developme...

    Call: DAINA 3 , Panel: NZ4

    Principal investigator: prof. Ewelina Knapska

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  41. Controlling the covalent activity of a PD-L1 inhibitors with light

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktor Uzar

    Uniwersytet Jagielloński w Krakowie

  42. Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

    Call: PRELUDIUM 23 , Panel: ST4

    Principal investigator: Monika Rola

    Politechnika Łódzka

  43. Frog skin derived cyclic peptide as a molecular scaffold to create a novel tool for combining visualization and inhibiti...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Aleksandra Helbik-Maciejewska

    Uniwersytet Gdański

  44. The expression of complement inhibitors in ovarian and corpus uteri cancers - a new perspective for immunotherapy

    Call: SONATA 1 , Panel: NZ7

    Principal investigator: dr hab. Lucyna Kapka-Skrzypczak

    Wyższa Szkoła Informatyki i Zarządzania w Rzeszowie, Wydział Turystyki i Nauk o Zdrowiu

  45. Identification of cytochrome P450 isoenzymes involved in the metabolism of levomepromazine in the human

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii PAN

  46. Identification and characterization of specific carp (Cyprinu carpio L) seminal plasma proteins – proteomics and classic...

    Call: SONATA 1 , Panel: NZ9

    Principal investigator: dr Mariola Dietrich

    Instytut Rozrodu Zwierząt i Badań Żywności Polskiej Akademii Nauk

  47. 3D structure-based search for selective inhibitor of thymidylate synthase of nematodes, a potential drug in chemotherapy...

    Call: OPUS 1 , Panel: NZ6

    Principal investigator: prof. Wojciech Rode

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  48. Defining the brain structures involved in delf-exposure (exploratory behavior) and partial inhibition of these structure...

    Call: PRELUDIUM 1 , Panel: HS6

    Principal investigator: Ita Robakiewicz

    Wyższa Szkoła Finansów i Zarządzania w Warszawie

  49. Function of DNA methylation and CNV-type polymorphisms of genes encoding metalloproteinase and their tissue inhibitors i...

    Call: OPUS 2 , Panel: NZ5

    Principal investigator: dr Edyta Majorczyk

    Politechnika Opolska, Wydział Wychowania Fizycznego i Fizjoterapii

  50. Multitarget approach to break the vicious circle of tau pathology and neuroinflammation in Alzheimer's disease: developm...

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński, Collegium Medicum